News Sentiment

IOVA sentiment intelligence

Iovance Biotherapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 42 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.23 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 34

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-1.9% over one week, +3.7% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Iovance Biotherapeutics (NASDAQ:IOVA) jumps 18%, adding a cash balance to its market value

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -1.9% Price digesting
Trend fit Trend active 3.7% over four weeks
Fair value -28.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 26
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 34
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
simplywall.st 8
Insider Monkey 3
Ad Hoc News 3
TechStock² 2
Stock Titan 2
Motley Fool 1
ChartMill 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 11
Regulatory and legal 7
Balance sheet 1
Deals and strategy 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 42